Zyflamend, a polyherbal mixture, down regulates class I and class II histone deacetylases and increases p21 levels in castrate-resistant prostate cancer cells

BACKGROUND: Zyflamend, a mixture containing extracts of ten herbs, has shown promise in a variety of preclinical cancer models, including prostate cancer. The current experiments were designed to investigate the effects of Zyflamend on the expression of class I and II histone deacetylases, a family...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, E-Chu, Zhao, Yi, Chen, Guoxun, Baek, Seung Joon, McEntee, Michael F, Minkin, Steven, Biggerstaff, John P, Whelan, Jay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3938081/
https://www.ncbi.nlm.nih.gov/pubmed/24555771
http://dx.doi.org/10.1186/1472-6882-14-68

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3938081/
https://www.ncbi.nlm.nih.gov/pubmed/24555771
http://dx.doi.org/10.1186/1472-6882-14-68

Ejemplares similares